Skip to Content
Cancer Therapy Evaluation Program (CTEP)
Contact NExT
Show menu
Search this site
Last Updated: 01/06/14

A. P. Chen, MD
Medical Officer

Dr. Chen is currently a Medical Officer in the Target Therapeutics 1 Section of the Investigational Drug Branch of the Cancer Therapy Evaluation Program of the National Cancer Institute. She is board certified in Internal Medicine and Medical Oncology. She has served as a primary and associate investigator in a broad spectrum of clinical trials ranging from phase 0 through phase 4. Her portfolio includes DNA binding agents and angiogenesis, integrin, HSP 90, PARP and topoisomerase inhibitors. Dr. Chen is also the CTEP contact for revision 4 of the Common Terminology Criteria for Adverse Events.

Contact Information:
National Cancer Institute
9609 Medical Center Dr., MSC 9739
For USPS: Bethesda, MD 20892-9739
For Express and Courier: Rockville, MD 20850
Phone: 240-276-6565
Fax: 240-276-7894

About the Branch Chief

Jeffrey A. Moscow, MD Jeffrey A. Moscow, MD, joined the Investigational Drug Branch (IDB) in 2014 after serving part time since 2012, and was appointed Branch Chief in 2018. He is a graduate of Harvard University and the Geisel School of Medicine at Dartmouth. Dr. Moscow completed his pediatric residency at the University of Texas Southwestern in Dallas and a fellowship in pediatric hematology-oncology in the Pediatric Oncology Branch, NCI. More…